Osteoporosis
Latest News
Preventing breaks and falls in older adults
“The idea that a “bone attack” is like a heart attack gets the message across.”
From the Journals
Risk assessment first urged for fragility fracture screening
A new guideline is aimed at primary care practitioners for their community-dwelling patients aged 40 and older.
Latest News
Osteoporosis and osteopenia: Latest treatment recommendations
It is strongly recommended that postmenopausal women with osteoporosis receive a bisphosphonate as first-line treatment to reduce the risk for...
Commentary
Bone-bashing effects of air pollution becoming clearer
Particulate matter induces systemic inflammation and an increase in cytokines that stimulate bone cells (osteoclasts) that cause bone loss.
Latest News
Osteoporosis drugs may extend life after fracture
The study’s findings suggest that bisphosphonates, in particular, have pleiotropic effects beyond the bone.
From the Journals
Holy smoke: Air pollution link to bone damage confirmed
‘The scientific literature ... is clearly pointing toward a negative effect of chronic pollution exposure on bone health,’ says expert. New study...
Perspectives
What impact do carbs have on bone health?
A high–glycemic index diet has been associated with a greater risk for obesity and cardiovascular disease, with lower bone density, and an...
Clinical Review
2023 Update on bone health
Study recaps and expert perspectives on SERMs and bone effects, the microbiome’s role in bone metabolism, the added risks of frailty, and...
Opinion
Geriatrician advises on use of vitamin D supplementation, lecanemab, and texting for her patients
There is growing awareness of the impact of social isolation on health outcomes, particularly among older adults.
Guidelines
New osteoporosis guideline says start with a bisphosphonate
Initial therapy with bisphosphonates for postmenopausal women with osteoporosis and men with osteoporosis are strongly recommended.
Latest News
Transgender patients on hormone therapy require monitoring
These patients have an increased mortality risk and so must be closely monitored, especially in terms of cardiovascular health and oncology.